Home » Topics » BioWorld Science

BioWorld Science
RSS

Gene therapy provides pain relief by resetting "corrupted" circuit

Oct. 29, 2021

Researchers develop a novel rotenone-induced murine model of bipolar disorder

Oct. 29, 2021

IL-2 partial agonist allows T-cell expansion without differentiation

Oct. 29, 2021

IACTA Pharmaceuticals receives funding to conduct preclinical studies of IC-800

Oct. 29, 2021

Novel AChE/GSK-3beta inhibitor shows promising activity in models of AD

Oct. 29, 2021

New PKP2-based gene therapy for ARVC treatment

Oct. 29, 2021

Bayer describes new anthelmintic compounds

Oct. 29, 2021

Camp Therapeutics identifies new antibacterial peptides

Oct. 29, 2021

Agios Pharmaceuticals, University of Michigan present menin/MLL interaction inhibitors

Oct. 29, 2021

New IL-17 modulators discovered at UCB

Oct. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...